Note 14 - Business Segments

9 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14. BUSINESS SEGMENTS

The Company operated in four segments: the testing service industry (which performs structural and electronic tests of semiconductor devices); the designing and manufacturing of equipment (assembly of equipment that tests the structural integrity of integrated circuits and other products); distribution of various products from other manufacturers in Singapore and Asia; and the real estate segment in China.

The cost of equipment, current year investment in new equipment and depreciation expense are allocated into respective segments based on the primary purpose for which the equipment was acquired.

Corporate expenses are allocated to the four segments on a combination of factors involving revenue, manpower costs and fixed assets investments. The following segment information table includes segment operating income or loss after including corporate expense allocated to the segments, which gets eliminated in the consolidation.

The following segment Information is unaudited for the nine months ended March 31, 2024, and March 31, 2023:

Business Segment Information:

	Nine Months			Operating
	Ended	Net		Income /			Total		Depr. and		Capital
	Mar. 31,	Revenue		(Loss)			Assets		Amort.		Expenditures
Manufacturing	2024	$	12,488	$	447		$	17,740	$	323	$	49
	2023	$	11,592	$	373		$	15,056	$	365	$	18
Testing Services	2024		13,606		(463	)		20,651		3,141		121
	2023		17,709		1,445			26,522		3,218		4,033
Distribution	2024		6,453		868			1,702		-		38
	2023		4,855		633			1,283		-		-
Real Estate	2024		19		(76	)		2,429		55		-
	2023		15		(76	)		1,872		58		-
Corporate & Unallocated	2024		-		(41	)		565		27		-
	2023		-		(276	)		641		-		26
Total Company	2024	$	32,566	$	735		$	43,087	$	3,546	$	208
	2023	$	34,171	$	2,099		$	45,374	$	3,641	$	4,077

The following segment Information is unaudited for the three months ended March 31, 2024, and March 31, 2023:

Business Segment Information:

	Three Months			Operating
	Ended	Net		Income /			Total		Depr. and		Capital
	Mar. 31,	Revenue		(Loss)			Assets		Amort.		Expenditures
Manufacturing	2024	$	4,813	$	298		$	17,740	$	108	$	11
	2023	$	2,963	$	(104	)	$	15,056	$	135	$	3
Testing Services	2024		3,796		(183	)		20,651		634		1
	2023		5,697		37			26,522		1,343		66
Distribution	2024		1,783		222			1,702		-		38
	2023		1,179		151			1,283		-		-
Real Estate	2024		6		(23	)		2,429		18		-
	2023		3		(34	)		1,872		20		-
Corporate & Unallocated	2024		-		(255	)		565		-		-
	2023		-		(87	)		641		-		14
Total Company	2024	$	10,398	$	59		$	43,087	$	760	$	50
	2023	$	9,842	$	(37	)	$	45,374	$	1,498	$	83

Management is currently evaluating the ongoing contributions of each of its business segments to its current and future revenue and prospects, including its Testing segment. As a result, it may divest one or more business segments in the future, including its Testing segment, to enable management to concentrate on segments where it anticipates opportunities for future revenue growth, thereby maximizing shareholder value.